Table 1 Clinical characteristics of 15 patients with non-familial Brugada syndrome without SCN5A variants

From: Disease-Targeted Sequencing of Ion Channel Genes identifies de novo mutations in Patients with Non-Familial Brugada Syndrome

Patient (BrS #)

Gender

Age at diagnosis (years)

Presentation

Circumstance

Documented Arrhythmias

FH of SCD or BrS

Baseline Brugada-type ECG

ICD Treatment

1

M

52

Syncope

Taking a shower

VT

Negative

Coved

Yes

2

M

38

Syncope/Seizure

At rest

NA

Negative

Coved

Yes

3

M

38

Syncope

Working

NA

Negative

Coved

Yes

4

M

49

SCD

At rest

VF

Negative

Coved

No

5

M

38

SCD

Working

VF

Negative

Coved

Yes

6

M

22

Syncope

At rest

NA

Negative

Saddle-back

No

7

M

33

Syncope

At rest

NA

Negative

Coved

No

8

M

39

Syncope

At rest

NA

Negative

Saddle-back

Yes

9

M

43

Syncope

At rest

NA

Negative

Coved

No

10

M

44

SCD

At rest

VT/VF

Negative

Coved

Yes

11

M

36

Syncope

At rest

NA

Negative

Coved

Yes

12

M

30

SCD

At rest

VT/VF

Negative

Coved

Yes

13

M

30

SCD

Sleeping

VF

Negative

Coved

Yes

14

M

49

Syncope

At rest

VF

Negative

Saddle-back

No

15

M

56

SCD

Sleeping

VF

Negative

Coved

Yes

  1. NA, not available; FH, family history; SCD, sudden cardiac death; BrS, Brugada syndrome; SNP, single nucleotide polymorphism; VF, ventricular fibrillation; VT, ventricular tachycardia; ICD, implantable cardioverter defibrillator.